<p>NEW YORK, Dec. 14, 2023 (GLOBE NEWSWIRE) — Tourmaline Bio, Inc. (“Tourmaline”) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dra
It is going to be all about how the market digests the Fed Meanwhile, Treasury yields fell further back into its previous range with Powell having said that yield curve control is "an open qu
Another positive set of results in US key indicators lent oxygen to the upside bias in the greenback and underpinned the tighter-for-longer narrative around the Fed.
Leave a Comment